The state of Illinois currently has 34 active clinical trials seeking participants for Hypertension research studies. These trials are conducted in various cities, including Chicago, Peoria, Springfield and Urbana.
Testing Feasibility of Medication Adherence Problem Solving for Hypertension
Recruiting
Adherence to medications for high blood pressure is key to improving blood pressure control and reducing the impact of cardiovascular disease. This project will test the feasibility of a tailored telehealth intervention to help patients improve adherence to blood pressure medication.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/30/2023
Locations: Rush University Medical Center, Chicago, Illinois
Conditions: Hypertension, Adherence, Medication
Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)
Recruiting
STEP-UP will promote linkage to primary care and ongoing chronic disease evaluation for postpartum women with prior gestational diabetes mellitus (GDM) and/or hypertensive disorders of pregnancy (HDP).
Gender:
Female
Ages:
18 years and above
Trial Updated:
11/02/2023
Locations: Cook County Health, Chicago, Illinois +1 locations
Conditions: Hypertension in Pregnancy, Gestational Diabetes Mellitus, Dysglycemia
Novartis - Closing the Gap in Cardiovascular Risk: Engage, Empower, Evaluate
Recruiting
This study aims to decrease the racial gap in high blood pressure in African American and Latinx patients in Rush University Medical Center clinics.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/28/2023
Locations: Rush University Medical Center, Chicago, Illinois
Conditions: Hypertension
Assessing Open Access Audio
Recruiting
The medical encounter can be overwhelming in term of the amount of information discussed, its technical nature, and the anxiety it can generate. Easy access to a secure audio recording from any internet enabled device is an available low cost technology that allows patients to "revisit the visit" either alone or sharing with caretakers and family. It has been introduced and tested outside the VA with evidence that it increases patient recall and understanding and may even improve physician perfo... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/19/2023
Locations: Jesse Brown VA Medical Center, Chicago, IL, Chicago, Illinois
Conditions: Hypertension, Diabetes
Watermelon Dose Response Blood Pressure Study
Recruiting
Primary outcome: To evaluate the dose response effects of watermelon flesh in regulating Blood Pressure (BP) in individuals with pre-hypertension. Secondary outcomes: To study the dose-response effects of watermelon flesh intake on cardio-metabolic risk factors including plasma metabolic markers, lipid profile and nitrate/nitrite levels in individuals with pre-hypertension.
Gender:
All
Ages:
Between 25 years and 65 years
Trial Updated:
05/26/2023
Locations: Clinical Nutrition Research Center, Chicago, Illinois
Conditions: Pre-hypertension, Cardiovascular Diseases
The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older
Recruiting
This is a multisite clinical trial of healthy lifestyle programs for middle-to-older-aged adults (50 -74 years) to improve their weight and, therefore, reduce risk for chronic disease. This study will investigate whether a proven, self-directed video-based lifestyle program can be significantly enhanced with the assistance of a coach via videoconference or phone to help people as they adopt healthy eating and exercise behaviors. Additionally, the study will examine what factors might explain why... Read More
Gender:
All
Ages:
Between 50 years and 74 years
Trial Updated:
05/08/2023
Locations: Department of Medicine, Vitoux Program on Aging and Prevention, Chicago, Illinois
Conditions: CARDIOMETABOLIC CONDITIONS, Obesity, Pre-diabetes, Metabolic Syndrome, Type2diabetes, Hypertension, Dyslipidemias
TIPS Plus Transvenous Obliteration for Gastric Varices
Recruiting
Variceal hemorrhage (VH) from gastric varices (GVs) results in significant morbidity and mortality among patients with liver cirrhosis. In cases of acute bleeding, refractory bleeding, or high risk GVs, the transjugular intrahepatic portosystemic shunt (TIPS) creation and transvenous variceal obliteration procedures have used to treat GVs. While these techniques are effective, each is associated with limitations, including non-trivial rebleeding and hepatic encephalopathy rates for TIPS and aggr... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/14/2023
Locations: University of Illinois at Chicago, Chicago, Illinois
Conditions: Cirrhosis, Liver, Hypertension, Portal, Esophageal and Gastric Varices, Bleeding Gastric, Encephalopathy
Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study
Recruiting
The objectives of this study are to evaluate the effects of RT234 on exercise parameters assessed by a specialized exercise test (Cardiopulmonary Exercise Test or CPET) in patients with pulmonary arterial hypertension (PAH).
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
02/09/2023
Locations: University of Chicago Medical Center, Chicago, Illinois
Conditions: Pulmonary Arterial Hypertension
Improving Hypertension Medication Adherence for Older Adults
Recruiting
This randomized controlled trial will assess the efficacy and scalability of a blood pressure technology system intervention. The investigators will enroll 224 older adults with hypertension to identify those who are nonadherent for one hypertension medication. The participants will be randomized to one of two groups (112 per group) to use the blood pressure system for 6-months. Both groups receive information about high blood pressure and medications. One group will also receive strategies that... Read More
Gender:
All
Ages:
65 years and above
Trial Updated:
01/26/2023
Locations: University of Illinois Urbana-Champaign, Champaign, Illinois
Conditions: Aging, Medication Adherence, Hypertension
Improving Blood Pressure and Cardiovascular Risk With Resistance Exercise in African Americans
Recruiting
After the participant meets all inclusion and exclusion criteria, they will be randomized equally to either the Resistance Training group (RT) or Aerobic Training group (AT). Both groups will participate in an 8 week initial control period, followed by 8 weeks of supervised exercise training, followed by 8 weeks of deconditioning. All participants will undergo the same assessments and procedures one time prior to the initial 8 week control period, and at each of the three periods. Assessments in... Read More
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
10/31/2022
Locations: University of Illinois at Chicago, Chicago, Illinois
Conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases